Only 12 active COVID-19 cases left among Central Luzon cops | Inquirer News

Only 12 active COVID-19 cases left among Central Luzon cops

Only 12 active COVID-19 cases left among Central Luzon cops

FILE PHOTO: A police officer gets vaccinated against COVID-19 at Camp Julian Olivas in the City of San Fernando, Pampanga province. (Photo from the Police Regional Office 3)

OLONGAPO CITY — The number of active COVID-19 cases among policemen in Central Luzon dropped to 12 on Wednesday as the Police Regional Office 3 (PRO3) did not record an additional infection for two consecutive days.

Data from the health service of the PRO3 showed that its current tally of active cases was the lowest in over a year since recording its first infection.


PRO3 has already posted zero daily new COVID-19 cases at least five times since October, sustaining the downward trend.

Data also showed that no new deaths related to the viral disease were registered by the PRO3 since October 15. Its COVID-19 death cases remained at seven.


Since last year, a total of 2,939 COVID-19 cases were logged among the workforce of the Philippine National Police in the region but at least 2,920 of these were recoveries. It reflected a 99.3-percent recovery rate.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: case bulletin, Central Luzon, COVID-19, PNP‎, PRO3
For feedback, complaints, or inquiries, contact us.

News that matters

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.